Search Result "MHC Class II Antigen"
TAP-Independent MHC Class I Presentation
Journal: Current Immunology Reviews
Volume: 2 Issue: 3 Year: 2006 Page: 233-245
Author(s): Mette Voldby Larsen, Morten Nielsen, Andreas Weinzierl, Ole Lund
Endothelial Expression of MHC Class II Molecules in Autoimmune Disease
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 2 Year: 2004 Page: 129-143
Author(s): Carl Turesson
Non-Canonical Peptides Bound to MHC
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 3274-3282
Author(s): Stephanie L. Day, Paul A. Ramsland, Vasso Apostolopoulos
Targeting Tumor-Associated Antigens to the MHC Class I Presentation Pathway
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 7 Issue: 2 Year: 2007 Page: 99-109
Author(s): G. Gross, A. Margalit
The Study of HLA Class II and Autoimmune Diabetes
Journal: Current Molecular Medicine
Volume: 3 Issue: 1 Year: 2003 Page: 1-15
Author(s): F. Susan Wong, Li Wen
Inhibition of MHC II Gene Transcription by Nitric Oxide and Antioxidants
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 8 Year: 2004 Page: 893-898
Author(s): Olivier Harari, James K. Liao
Use of MHC II Structural Features in the Design of Vaccines for Organ-Specific Autoimmune Diseases
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 3262-3273
Author(s): Antonis K. Moustakas, George K. Papadopoulos
MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9 Issue: 4 Year: 2009 Page: 344-352
Author(s): Arvind Chhabra
MHC and Cancer Immunotherapy
Ebook: Personalized Immunotherapy for Tumor Diseases and Beyond
Volume: 1 Year: 2020
Author(s): Li-Hua Jiang,Wei-Hua Yan
Doi: 10.2174/97898114827551200101
Docking Analysis of Deltamethrin Pesticide with MHC I and MHC IIMolecules to Establish Immunomodulation Effects
Journal: Current Signal Transduction Therapy
Volume: 18 Issue: 2 Year: 2023 Page: 60-67
Author(s):